JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Home
Signaling Pathways

Signaling Pathways

A3374 Dronedarone

Target: Cytochrome P450 (CYP450)|sodium channel|adrenergic receptor|potassium channel|calcium channel

Summary: CYP3A4 and 2D6 inhibitor,moderate

≥27.84 mg/mL
B1358 Epinephrine Bitartrate

Target: adrenergic receptor

Summary: Adrenergic receptor agonist

insoluble in EtOH; ≥16.66 mg/mL
B1572 Latrepirdine

Target: Voltage-gated Calcium Channels (CaV)|NMDA receptor|adrenergic receptor|Histamine receptors|GluR|5-HT receptor|dopamine receptors|AMPA receptor

Summary: Brain cell death inhibitor

insoluble in H2O; ≥19.62 mg/mL
B1337 L-Adrenaline

Target: adrenergic receptor

Summary: Adrenergic receptor agonist

insoluble in EtOH; insoluble in H2O; ≥4.58 mg/mL
A3744 Quetiapine

Target: AChR|adrenergic receptor|5-HT receptor|Dopamine receptor|Histamine receptor

Summary: Dopamine receptor antagonist

insoluble in H2O; ≥19.18 mg/mL